SAS Output

19-NOV-2017 6:10

GU ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1314-Blad, COXEN Neoadj. Chemo + Cyst 1 Y 1 GC+CYST 230 118 43 22 10 2 0 08/28/2014 212 108
        2 DDMVAC+CYST   115 43 21 10 4 0      
            233 86 43 20 6 0      
 
  S1500-pRCC,Adv, Sunitinib vs MET inhib 1 Y 1 Sunitinib 180 15 13 6 3 2 0 07/25/2016 207 92
        2 Cabozantinib   13 9 4 4 1 0      
        3 Crizotinib   14 10 4 3 1 1      
        4 Savolitinib   14 11 3 2 1 1      
            56 43 17 12 5 2      
 
  S1602-Blad, HG NMIBC, TICE/Tokyo/Prime+Tokyo BCG 1 Y 1 TICE BCG 969 17 17 13 9 3 1 02/24/2017 143 64
        2 Tokyo-172 BCG   16 16 14 9 3 1      
        3 Prime + Tokyo-172 BCG   18 18 16 11 6 2      
            51 51 43 29 12 4      
 
  S1605-Blad, BCG-Unresponsive NMIBC, Atezolizumab 1 Y 1 Atezolizumab 148 21 21 19 14 6 2 03/13/2017 140 63
            21 21 19 14 6 2      
 
Yes A031102-GCT, Recur, Std Chemo(TIP) vs HD Chemo(TI-CE) 1 E Total Registrations   2 2 0 0 0 0 11/23/2016 59 35
            2 2 0 0 0 0      
 
  EA8143-RCC, HR, Surg +/- Nivolumab (PROSPER) 0 E Total Registrations   5 5 5 5 2 1 09/29/2017   4
            5 5 5 5 2 1      
 
    1 E Total Registrations   3 3 3 3 0 0 09/29/2017    
            3 3 3 3 0 0      
 
  NRGGU002-Pros, RT + ADT After RP +/- Adj Docetaxel 1 E Total Registrations   1 1 1 1 0 0 08/24/2017   103
            1 1 1 1 0 0      
 
    2 E Total Registrations   1 1 1 1 0 0 08/24/2017    
            1 1 1 1 0 0      
 
No EA8141-UTUC, HG, Chemo then Surg 1 E Total Registrations   8 3 0 0 0 0 02/23/2016 154 75
            8 3 0 0 0 0      
 
  R0924-Pros, NADT+WPRT vs. NADT+P&SV RT 1 E Total Registrations   58 30 13 7 3 2 11/25/2013   162
            58 30 13 7 3 2